Gilead and Aelix first teamed up in 2018 for a clinical research collaboration agreement to investigate the vaccine.

Spanish HIV focused immunotherapies company AELIX Therapeutics, a spin-off of IrisCaixa, has announced the acquisition of its ...

Women – especially teen girls and young women living in sub-Saharan Africa – are disproportionately impacted by <a ...

In Uganda, women and girls are more affected by HIV. Out of 1.4 million people living with the disease, 860 000 are women and ...

As the U.S. prepares to welcome a new presidential administration, leaders from business, public health, and community ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Long-awaited results released Tuesday showed adding tiragolumab to Roche's immunotherapy Tecentriq did not extend survival in ...

The discussion happened before Trump’s nomination of Robert F. Kennedy Jr. to serve as HHS secretary, Dave Weldon for ...

Grace Place: 2024 Haus of Gingerbread Haus of Gingerbread, benefitting the youth of Grace Place, is even bigger and better ...

Roche RHHBY announced that it will acquire clinical-stage biopharmaceutical company Poseida Therapeutics, Inc. PSTX for $9 ...

Roche’s Skyscraper-01 has fallen down. The phase 3 trial found adding the TIGIT candidate tiragolumab to a checkpoint ...